GeneDx Holdings Corp Earnings Dividend

GeneDx Holdings Corp’s revenue jumped 26.5% since last year same period to $120.99Mn in the Q4 2025. On a quarterly growth basis, GeneDx Holdings Corp has generated 3.64% jump in its revenue since last 3-months.

GeneDx Holdings Corp’s net profit fell -424.86% since last year same period to $-17.67Mn in the Q4 2025. On a quarterly growth basis, GeneDx Holdings Corp has generated -131.38% fall in its net profits since last 3-months.

GeneDx Holdings Corp’s net profit margin fell -356.8% since last year same period to -14.6% in the Q4 2025. On a quarterly growth basis, GeneDx Holdings Corp has generated -123.26% fall in its net profit margins since last 3-months.

GeneDx Holdings Corp’s earning per share (EPS) estimates for the current quarter stand at -0.05 - a -155.87% fall from last quarter’s estimates.

GeneDx Holdings Corp’s earning per share (EPS) estimates for the current year stand at -0.05.

GeneDx Holdings Corp’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the GeneDx Holdings Corp has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.